Farther Finance Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
MSV
KFP
RT
AAA
TFA
VCM
BFA
GI
BE
Farther Finance Advisors's BMY Position: Q3 2026 in Review
Farther Finance Advisors increased its Bristol-Myers Squibb (BMY) stake by 28% in Q3 2026, buying an estimated $2.62M and bringing the position to 189,513 shares worth $11.8M. The position accounts for 0.08% of the portfolio, ranked #204.
Farther Finance Advisors first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. 86 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Farther Finance Advisors held 189,513 shares of Bristol-Myers Squibb worth $11.8M as of Q3 2026.
- Farther Finance Advisors bought 41,496 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.62M.
- Bristol-Myers Squibb made up 0.08% of Farther Finance Advisors's portfolio in Q3 2026, its #204 holding.
- Farther Finance Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
- 86 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.